Boston, MA - Assays for the fibrin-degradation product d-dimer could potentially be used to identify patients on oral anticoagulants to treat venous thromboembolism (VTE) who are at high risk for ...
D-dimer can be used to exclude venous thromboembolism (VTE) in outpatients. Together with a low pretest probability for VTE, a negative D-dimer can safely rule out VTE in 30-50 % of patients with ...
The use of a tandem serial measurement of circulating EBV DNA for the outpatient screening of EBV associated nasophayngeal carcinoma Prediction of response to therapy based on tumor biology, which ...
Venous thromboembolism (VTE) is a common disease that affects as many as 900,000 Americans yearly with an estimated 60,000 - 100,000 Americans dying each year as a result of VTE. D-Dimer levels ...
HORIBA UK Ltd, Medical announces the launch of a D-Dimer parameter for its Yumizen G hemostasis range of instruments. The new Yumizen GDDi 2 (D-Dimer) reagent kit is now available for HORIBA Medical’s ...
Myc is a transcriptional regulator of the basic helix-loop-helix leucine zipper protein family. It has strong oncogenic potential, mutated or virally transduced forms of Myc induce lymphoid tumors in ...
The finding in patients who had experienced a first episode of deep-venous thrombosis or pulmonary embolism suggests that the d-dimer test "may be useful in guiding the duration of anticoagulation by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback